Gut microbiota and obesity: Involvement of the adipose tissue

Journal of Functional Foods

Volumn 14, Issue , 2015, Pages 407-423

  Guida, Sonia ^a   Venema, Koen ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adipose tissue; Endocannabinoid system; Gut microbiota; Inflammation; Obesity; Probiotics

Indexed keywords

EID: 84926295375     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.02.014     Document Type: Review

References (74)

1. Aguirre M., Jonkers D.M., Troost F.J., Roeselers G., Venema K. In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects. PLoS ONE 2014, 9(11):e113864.
2. Ahima R.S., Flier J.S. Leptin. Annual Review of Physiology 2000, 62:413-437. 10.1146/annurev.physiol.62.1.413.
3. Al-Lahham S.H., Roelofsen H., Priebe M., Weening D., Dijkstra M., Hoek A., Rezaee F., Venema K., Vonk R.J. Regulation of adipokine production in human adipose tissue by propionic acid. European Journal of Clinical Investigation 2010, 40(5):401-407. 10.1111/j.1365-2362.2010.02278.x.
4. Al-Lahham S., Roelofsen H., Rezaee F., Weening D., Hoek A., Vonk R., Venema K. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. European Journal of Clinical Investigation 2012, 42(4):357-364. 10.1111/j.1365-2362.2011.02590.x.
5. Annalisa N., Alessio T., Claudette T.D., Erald V., de Antonino L., Nicola D.D. Gut microbioma population: An indicator really sensible to any change in age, diet, metabolic syndrome, and life-style. Mediators of Inflammation 2014, 2014:901308. 10.1155/2014/901308.
6. Arango Duque G., Descoteaux A. Macrophage cytokines: Involvement in immunity and infectious diseases. Frontiers Immunology 2014, 5:491. 10.3389/fimmu.2014.00491.
7. Aronsson L., Huang Y., Parini P., Korach-Andre M., Hakansson J., Gustafsson J.A., Pettersson S., Arulampalam V., Rafter J. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE 2010, 5(9). 10.1371/journal.pone.0013087.
8. Arora T., Anastasovska J., Gibson G., Tuohy K., Sharma R.K., Bell J., Frost G. Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet-induced obese mice. The British Journal of Nutrition 2012, 108(8):1382-1389. 10.1017/S0007114511006957.
9. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(44):15718-15723. 10.1073/pnas.0407076101.
10. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(3):979-984. 10.1073/pnas.0605374104.
11. Barrett K.E. Functional anatomy of the GI tract and organs draining into it. Gastrointestinal physiology 2014, The McGraw-Hill Companies, New York. 2nd ed.
12. Barrett K.E., Boitano S., Barman S.M., Brooks H.L. General principles & energy production in medical physiology. Ganong's review of medical physiology 2012, The McGraw-Hill Companies, New York. 24th ed.
13. Barrett K.E., Boitano S., Barman S.M., Brooks H.L. Digestion, absorption, & nutritional principles. Ganong's review of medical physiology 2012, The McGraw-Hill Companies, New York. 24th ed.
14. Bindels L.B., Dewulf E.M., Delzenne N.M. GPR43/FFA2: Physiopathological relevance and therapeutic prospects. Trends in Pharmacological Sciences 2013, 34(4):226-232. 10.1016/j.tips.2013.02.002.
15. Bjursell M., Admyre T., Goransson M., Marley A.E., Smith D.M., Oscarsson J., Bohlooly Y.M. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. American Journal of Physiology. Endocrinology and Metabolism 2011, 300(1):E211-E220. 10.1152/ajpendo.00229.2010.
16. Brooks G.F., Carroll K.C., Butel J.S., Morse S.A., Mietzner T.A. Cell structure. Jawetz, Melnick, & Adelberg's medical microbiology 2013, The McGraw-Hill Companies, New York. 26th ed.
17. Bussolo de Souza C., Roeselers G., Troost F., Jonkers D., Koenen M.E., Venema K. Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota. Journal of Functional Foods 2014, 11:210-220. 10.1016/j.jff.2014.09.019.
18. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772. 10.2337/db06-1491.
19. Cani P.D., Geurts L., Matamoros S., Plovier H., Duparc T. Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. Diabetes & Metabolism 2014, 10.1016/j.diabet.2014.02.004.
20. Christodoulides C., Vidal-Puig A. PPARs and adipocyte function. Molecular and Cellular Endocrinology 2010, 318(1-2):61-68. 10.1016/j.mce.2009.09.014.
21. Cinti S. The adipose organ at a glance. Disease Models Mechanisms 2012, 5(5):588-594. 10.1242/dmm.009662.
22. Clement K. Bariatric surgery, adipose tissue and gut microbiota. International Journal of Obesity (2005) 2011, 35(Suppl. 3):S7-S15. 10.1038/ijo.2011.141.
23. Cohen D.E., Anania F.A. Nonalcoholic fatty liver disease. CURRENT diagnosis & treatment: gastroenterology, hepatology, & endoscopy 2012, The McGraw-Hill Companies, New York. 2nd ed. N.J. Greenberger, R.S. Blumberg, R. Burakoff (Eds.).
24. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., Ayav A., Ziegler O., Carpene C., Saulnier-Blache J.S., Valet P., Castan-Laurell I. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. The FASEB Journal 2006, 20(9):1528-1530. 10.1096/fj.05-5243fje.
25. Dewulf E.M., Cani P.D., Neyrinck A.M., Possemiers S., Van Holle A., Muccioli G.G., Deldicque L., Bindels L.B., Pachikian B.D., Sohet F.M., Mignolet E., Francaux M., Larondelle Y., Delzenne N.M. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. The Journal of Nutritional Biochemistry 2011, 22(8):712-722. 10.1016/j.jnutbio.2010.05.009.
26. Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. The British Journal of Nutrition 2010, 104(6):919-929. 10.1017/S0007114510001303.
27. Flier J.S., Maratos-Flier E. Biology of obesity. Harrison's principles of internal medicine 2012, The McGraw-Hill Companies, New York. 18th ed. D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds.).
28. Flint H.J. Obesity and the gut microbiota. Journal of Clinical Gastroenterology 2011, 45(Suppl):S128-S132. 10.1097/MCG.0b013e31821f44c4.
29. Furuya D.T., Poletto A.C., Freitas H.S., Machado U.F. Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-kappaB and sterol regulatory element-binding protein-1 in adipocytes. Journal of Molecular Endocrinology 2012, 49(2):97-106. 10.1530/JME-12-0037.
30. Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., Lefevre M., Cefalu W.T., Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58(7):1509-1517. 10.2337/db08-1637.
31. Geurts L., Neyrinck A.M., Delzenne N.M., Knauf C., Cani P.D. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics. Beneficial Microbes 2014, 5(1):3-17. 10.3920/BM2012.0065.
32. Go G.W., Oh S., Park M., Gang G., McLean D., Yang H.S., Song M.H., Kim Y. t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation. Journal of Microbiology and Biotechnology 2013, 23(11):1569-1576.
33. Hamad E.M., Sato M., Uzu K., Yoshida T., Higashi S., Kawakami H., Kadooka Y., Matsuyama H., Abd El-Gawad I.A., Imaizumi K. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. The British Journal of Nutrition 2009, 101(5):716-724. 10.1017/S0007114508043808.
34. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: The role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 2008, 27(2):104-119. 10.1111/j.1365-2036.2007.03562.x.
35. Han S., Wang G., Qi X., Englander E.W., Greeley G.H. Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 295(5):G1068-G1078. 10.1152/ajpgi.90493.2008.
36. Hong Y.H., Nishimura Y., Hishikawa D., Tsuzuki H., Miyahara H., Gotoh C., Choi K.C., Feng D.D., Chen C., Lee H.G., Katoh K., Roh S.G., Sasaki S. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 2005, 146(12):5092-5099. 10.1210/en.2005-0545.
37. Ishimwe N., Daliri E.B., Lee B.H., Fang F., Du G. The perspective on cholesterol lowering mechanisms of probiotics. Molecular Nutrition and Food Research 2014, 10.1002/mnfr.201400548.
38. Julio-Pieper M., Bravo J.A., Aliaga E., Gotteland M. Review article: Intestinal barrier dysfunction and central nervous system disorders - A controversial association. Alimentary Pharmacology and Therapeutics 2014, 40(10):1187-1201. 10.1111/apt.12950.
39. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 2005, 1(1):15-25. 10.1016/j.cmet.2004.12.003.
40. Kanaya A.M., Vaisse C. Obesity. Greenspan's basic & clinical endocrinology 2011, The McGraw-Hill Companies, New York. 9th ed. D.G. Gardner, D. Shoback (Eds.).
41. Kaushansky K. Signal transduction pathways. Williams hematology 2010, The McGraw-Hill Companies, New York. 8th ed. M.A. Lichtman, T.J. Kipps, U. Seligsohn, K. Kaushansky, J.T. Prchal (Eds.).
42. Kim M.H., Kang S.G., Park J.H., Yanagisawa M., Kim C.H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 2013, 145(2):396-406. e391-310. 10.1053/j.gastro.2013.04.056.
43. Kimura I., Inoue D., Hirano K., Tsujimoto G. The SCFA receptor GPR43 and energy metabolism. Frontiers in Endocrinology (Lausanne) 2014, 5:85. 10.3389/fendo.2014.00085.
44. Kondo S., Xiao J.Z., Satoh T., Odamaki T., Takahashi S., Sugahara H., Yaeshima T., Iwatsuki K., Kamei A., Abe K. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience, Biotechnology, and Biochemistry 2010, 74(8):1656-1661. 10.1271/bbb.100267.
45. Kotzampassi K., Giamarellos-Bourboulis E.J., Stavrou G. Obesity as a consequence of gut bacteria and diet interactions. ISRN Obesity 2014, 2014:651895. 10.1155/2014/651895.
46. Kushner R.F. Evaluation and management of obesity. Harrison's principles of internal medicine 2012, The McGraw-Hill Companies, New York. 18th ed. D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds.).
47. Lanthier N., Leclercq I.A. Adipose tissues as endocrine target organs. Best Practice and Research. Clinical Gastroenterology 2014, 28(4):545-558. 10.1016/j.bpg.2014.07.002.
48. Levinson W. Pathogenesis review of medical microbiology and immunology 2014, McGraw-Hill Education, New York. 13th ed.
49. Lin H.V., Frassetto A., Kowalik E.J., Nawrocki A.R., Lu M.M., Kosinski J.R., Hubert J.A., Szeto D., Yao X., Forrest G., Marsh D.J. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 2012, 7(4):e35240. 10.1371/journal.pone.0035240.
50. Mattijssen F., Alex S., Swarts H.J., Groen A.K., van Schothorst E.M., Kersten S. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Molecular Metabolism 2014, 3(2):135-144. 10.1016/j.molmet.2013.11.004.
51. McFarland L.V. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: A systematic review. BMJ Open 2014, 4(8):e005047. 10.1136/bmjopen-2014-005047.
52. Melgar-Lesmes P., Pauta M., Reichenbach V., Casals G., Ros J., Bataller R., Morales-Ruiz M., Jimenez W. Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut 2011, 60(10):1404-1411. 10.1136/gut.2010.234690.
53. Moreno-Indias I., Cardona F., Tinahones F.J., Queipo-Ortuno M.I. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Frontiers Microbiology 2014, 5:190. 10.3389/fmicb.2014.00190.
54. Muccioli G.G., Naslain D., Backhed F., Reigstad C.S., Lambert D.M., Delzenne N.M., Cani P.D. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 2010, 6:392. 10.1038/msb.2010.46.
55. Nieuwdorp M., Gilijamse P.W., Pai N., Kaplan L.M. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014, 146(6):1525-1533. 10.1053/j.gastro.2014.02.008.
56. Paulsen D.F. Adipose tissue. Histology & cell biology: Examination & board review 2010, The McGraw-Hill Companies, New York. 5th ed.
57. Proksch E., Jensen J.-M. Skin as an organ of protection. Fitzpatrick's dermatology in general medicine 2012, The McGraw-Hill Companies, New York. 8th ed. L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A.S. Paller, D.J. Leffell, K. Wolff (Eds.).
58. Rebello C., Greenway F.L., Dhurandhar N.V. Functional foods to promote weight loss and satiety. Current Opinion in Clinical Nutrition and Metabolic Care 2014, 17(6):596-604. 10.1097/MCO.0000000000000110.
59. Remely M., Aumueller E., Jahn D., Hippe B., Brath H., Haslberger A.G. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Beneficial Microbes 2014, 5(1):33-43. 10.3920/BM2013.006.
60. Sanchez M., Darimont C., Drapeau V., Emady-Azar S., Lepage M., Rezzonico E., Ngom-Bru C., Berger B., Philippe L., Ammon-Zuffrey C., Leone P., Chevrier G., St-Amand E., Marette A., Dore J., Tremblay A. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. The British Journal of Nutrition 2014, 111(8):1507-1519. 10.1017/S0007114513003875.
61. Sanz Y., Rastmanesh R., Agostoni C. Understanding the role of gut microbes and probiotics in obesity: How far are we?. Pharmacological Research 2013, 69(1):144-155. 10.1016/j.phrs.2012.10.021.
62. Schmidt J., Smith N.J., Christiansen E., Tikhonova I.G., Grundmann M., Hudson B.D., Ward R.J., Drewke C., Milligan G., Kostenis E., Ulven T. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: Identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. The Journal of Biological Chemistry 2011, 286(12):10628-10640. 10.1074/jbc.M110.210872.
63. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., Hardt P.D. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010, 18(1):190-195. 10.1038/oby.2009.167.
64. Sullivan D.H., Johnson L.E. Nutrition and aging. Hazzard's geriatric medicine and gerontology 2009, The McGraw-Hill Companies, New York. 6th ed. J.B. Halter, J.G. Ouslander, M.E. Tinetti, S. Studenski, K.P. High, S. Asthana (Eds.).
65. Tagliabue A., Elli M. The role of gut microbiota in human obesity: Recent findings and future perspectives. Nutrition, Metabolism, and Cardiovascular Diseases 2013, 23(3):160-168. 10.1016/j.numecd.2012.09.002.
66. Tontonoz P., Spiegelman B.M. Fat and beyond: The diverse biology of PPARgamma. Annual Review of Biochemistry 2008, 77:289-312. 10.1146/annurev.biochem.77.061307.091829.
67. Travis A.C., Blumberg R.S. Diverticular disease of the colon. Current diagnosis & treatment: Gastroenterology, hepatology, & endoscopy 2012, The McGraw-Hill Companies, New York. 2nd ed. N.J. Greenberger, R.S. Blumberg, R. Burakoff (Eds.).
68. Trayhurn P., Wood I.S. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. The British Journal of Nutrition 2004, 92(3):347-355.
69. Venema K. Role of gut microbiota in the control of energy and carbohydrate metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2010, 13(4):432-438. 10.1097/MCO.0b013e32833a8b60.
70. Wang H., Eckel R.H. Lipoprotein lipase: From gene to obesity. American Journal of Physiology. Endocrinology and Metabolism 2009, 297(2):E271-E288. 10.1152/ajpendo.90920.2008.
71. Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., Yanagisawa M. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(4):1045-1050. 10.1073/pnas.2637002100.
72. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of Clinical Investigation 2003, 112(12):1821-1830. 10.1172/JCI19451.
73. Yoo S.R., Kim Y.J., Park D.Y., Jung U.J., Jeon S.M., Ahn Y.T., Huh C.S., McGregor R., Choi M.S. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 2013, 21(12):2571-2578. 10.1002/oby.20428.
74. Zaibi M.S., Stocker C.J., O'Dowd J., Davies A., Bellahcene M., Cawthorne M.A., Brown A.J., Smith D.M., Arch J.R. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Letters 2010, 584(11):2381-2386. 10.1016/j.febslet.2010.04.027.